Karah Herdman Parschauer Ultragenyx Pharmaceutical Inc. (RARE) insider trading activity

Karah Herdman Parschauer is EVP and Chief Legal Officer of Ultragenyx Pharmaceutical Inc.. Currently has a direct ownership of 75,287 shares of RARE, which is worth approximately $2.12 Million. The most recent transaction as insider was on Oct 08, 2020, when has been sold 10,000 shares (Common Stock) at a price of $95.0 per share, resulting in proceeds of $950,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 75.3K

0% 3M change

29.85% 12M change

Total Value Held $2.12 Million

Karah Herdman Parschauer Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 08 2020	SELL Open market or private sale	$950,000 $95.0 p/Share	10,000 Reduced 29.16%	24,293 Common Stock
Oct 08 2020	BUY Exercise of conversion of derivative security	$545,000 $54.5 p/Share	10,000 Added 22.58%	34,293 Common Stock
Oct 06 2020	SELL Open market or private sale	$900,000 $90.0 p/Share	10,000 Reduced 29.16%	24,293 Common Stock
Oct 06 2020	BUY Exercise of conversion of derivative security	$484,300 $48.43 p/Share	10,000 Added 22.58%	34,293 Common Stock

Also insider at

EOLS

Evolus, Inc. Healthcare

Director

ARCT

Arcturus Therapeutics Holdings Inc. Healthcare

Director

TNYA

Tenaya Therapeutics, Inc. Healthcare

ANEB

Anebulo Pharmaceuticals, Inc. Healthcare

Director

KHP